PRELUDE THERAPEUTICS INCORPORATED - COMMON STOCK

Jane Huang, M.D., Joins Prelude Therapeutics as President and Chief Medical Officer

09 مارس 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

11 فبراير 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference

04 يناير 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics to Participate at the 4th Annual Evercore ISI HealthCONx Conference

23 نوفمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Third Quarter 2021 Financial Results and Operations Update

12 نوفمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor

08 نوفمبر 2021 09:00:01 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Presentation of Encouraging Data from Multiple Programs at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

07 أكتوبر 2021 09:00:01 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences

02 سبتمبر 2021 07:00:02 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update

12 أغسطس 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Appointment of Martin Babler to its Board of Directors

19 يوليو 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences

02 يونيو 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces First Quarter 2021 Financial Results and Operations Update

11 مايو 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Presentation at BofA Securities 2021 Virtual Health Care Conference

05 مايو 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Update

16 مارس 2021 08:00:02 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Participation at Three Upcoming Virtual Investor Conferences

03 مارس 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

11 يناير 2021 18:20:00 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Pricing of Upsized Public Offering

07 يناير 2021 00:12:43 بحسب Nasdaq GlobeNewswire

Prelude Therapeutics Announces Launch of Proposed Public Offering

04 يناير 2021 16:16:38 بحسب Nasdaq GlobeNewswire